The short version

From the latest prices and each company's SEC filings. Who's ahead on each measure, not which to buy.

  • CVS Health is the larger company, worth $109.7B, about 44.5 times Clover Health Investments.
  • Clover Health Investments grew revenue faster over the last year (+55.6% vs +7.3%).
  • CVS Health keeps more of each dollar of revenue as operating profit (2.0% vs -0.7%).

Side by side

The stronger figure is shaded where higher (or, for valuation multiples, lower) reads as better. How the implied growth works.

MeasureCLOVCVS
Market cap$2.5B$109.7B
Share price$4.79$87.95
Revenue (last fiscal year)$1.9B$402.1B
Free cash flow (last fiscal year)-$69M$7.8B
Revenue growth, last year+55.6%+7.3%
Revenue growth per year, last 5 fiscal years+6.9%+8.3%
Operating margin-0.74%2.0%
Net margin-0.74%1.2%
Return on equity-4.9%6.1%
P/E (trailing)—37.7x
Price / free cash flow—14.0x
EV / EBITDA—12.6x
FCF growth the price implies—0.36%
Dividend yield—3.1%
Debt / equity0.91x2.18x
Fundamental gradeDC
Superinvestors holding it114
Insider purchases, last 12 months06

Results from SEC filings

Revenue and free cash flow by fiscal year, from each company's 10-K filings.

Clover Health Investments

YearRevenueFree cash flowOp. margin
2021$1.5B-$283M-43.3%
2022$1.1B-$208M-26.1%
2023$1.3B-$145M-16.3%
2024$1.4B$33M-3.3%
2025$1.9B-$69M-4.4%

CVS Health

YearRevenueFree cash flowOp. margin
2021$292.1B$15.7B4.6%
2022$322.5B$13.4B2.5%
2023$357.8B$10.4B3.8%
2024$372.8B$6.3B2.3%
2025$402.1B$7.8B1.2%

Where the revenue comes from

Clover Health Investments

No segment breakdown reported.

CVS Health · by segments, 2025

Health Services$190.4B40%
Health Care Benefits$143.4B30%
Pharmacy & Consumer Wellness$139.4B29%
Compare them in fullFifteen years of statements, quarterly results, DCF and IRR models, and any number of peers side by side.
Open CLOV in Investingly

Questions

Which is bigger, Clover Health Investments or CVS Health?

CVS Health (CVS), at $109.7B against $2.5B.

Which grows faster, CLOV or CVS?

Clover Health Investments: revenue grew +55.6% over the last year, against +7.3%.

Prices and ratios as of the last daily update; statements from SEC filings. Information only, not investment advice.